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  GENERAL ORTHOPAEDICS
Theatre efficiency in COVID- 19 pandemic 
conditions: The collaborative experience 
of four level 1 major trauma centres in 
the UK
Aims
As the world continues to fight successive waves of COVID- 19 variants, we have seen world-
wide infections surpass 100 million. London, UK, has been severely affected throughout the 
pandemic, and the resulting impact on the NHS has been profound. The aim of this study is 
to evaluate the impact of COVID- 19 on theatre productivity across London’s four major trau-
ma centres (MTCs), and to assess how the changes to normal protocols and working patterns 
impacted trauma theatre efficiency.
Methods
This was a collaborative study across London’s MTCs. A two- month period was selected 
from 5 March to 5 May 2020. The same two- month period in 2019 was used to provide 
baseline data for comparison. Demographic information was collected, as well as surgi-
cal speciality, procedure, time to surgery, type of anaesthesia, and various time points 
throughout the patient journey to theatre.
Results
In total, 1,243 theatre visits were analyzed as part of the study. Of these, 834 patients 
presented in 2019 and 409 in 2020. Fewer open reduction and internal fixations were 
performed in 2020 (33.5% vs 38.2%), and there was an increase in the number of orthop-
lastic cases in 2020 (8.3% vs 2.2%), both statistically significant results (p < 0.000). There 
was a statistically significant increase in median time from 2019 to 2020, between send-
ing for a patient and their arrival to the anaesthetic room (29 vs 35 minutes; p = 0.000). 
Median time between arrival in the anaesthetic room and commencement of anaesthetic 
increased (7 to 9 minutes; p = 0.104).
Conclusion
Changes in working practices necessitated by COVID- 19 led to modest delays to all aspects 
of theatre use, and consequently theatre efficiency. However, the reality is that the major 
concerns of impact of service did not occur to the levels that were expected.
Cite this article: Bone Jt Open 2021;2-10:886–892.
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Introduction
As the world continues to fight succes-
sive waves of COVID- 19 variants, we have 
seen global infections surpass 100 million, 
with over two million deaths at the time of 
writing.1 The UK has been one of the worst 
affected regions and currently stands fifth in 
the world in terms of infections and deaths.1
London, UK, has been severely affected 
throughout the pandemic.2 The resulting 
impact on the NHS during peaks of COVID- 19 
cases has been profound, with emergency 
trauma and orthopaedic care being severely 
impacted. Delivery of trauma care across 
all four of London’s major trauma centres 
(MTCs; The Royal London Hospital, King's 
College Hospital, St George's Hospital, and 
St Mary's Hospital) was restructured as 
part of an emergency response, diverting 
resources to manage the COVID- 19 burden.3
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Operating theatre staff and anaesthetists were rede-
ployed to critical care units, reducing capacity. There 
were also major amendments to anaesthetic protocols, 
infection control measures, and use of personal protec-
tive equipment (PPE), which appeared to impact produc-
tivity and reduce efficiency and turnover.
The aim of this study is to evaluate the impact of 
COVID- 19 on theatre productivity across London’s MTCs, 
and to assess how the changes to normal protocols and 
working patterns impacted trauma theatre efficiency.
Methods
This was a collaborative study across all four of London’s 
MTCs. A two- month period was selected to compare to 
a period just prior to and during the first lockdown, from 
5 March to 5 May 2020. The same two- month period in 
2019 was used to provide baseline data for comparison.
Inclusion criteria were any individual undergoing a 
surgical procedure during the defied time periods, and 
patient and theatre records for all the pre- defined assess-
ment parameters. Any incomplete records and non- 
emergency cases were excluded.
Data was collected at individual sites and collated 
for analysis as a single dataset. Data sampling for each 
site was standardized. All patients were identified by 
searching computerized theatre records, with all those 
undergoing procedures during the defined timeframe 
included in the study. Data regarding demographics was 
obtained by retrospective review of the computerized 
patient record. This was also used to review the operation 
notes and to document the exact procedures that were 
performed. All timings data was collected by review of 
the electronic theatre records, where data is input at the 
time of the procedure by theatre scrub staff. These prac-
tices and records are standardized across all four sites.
Every emergency surgical case performed during the 
study periods was included, provided that full data was 
available on the electronic record. Baseline demographic 
information was collected, as well as surgical speciality, 
procedure, time to surgery, type of anaesthesia, the time 
between sending for and arrival in the anaesthetic room, 
time between anaesthetic room arrival and start of anaes-
thesia, overall anaesthesia time, overall procedure time, 
and overall theatre time.
Once individual site data was collected, the data 
was pooled for all four sites. Further records that were 
incomplete were removed from the data set. The final, 
complete four- site data set was then statistically analyzed 
(as described below). The study was registered with the 
research and audit department of each participating UK 
centre. As we were using routinely collected anonymized 
data, formal research ethics approval was not required.
Statistical analysis. The years 2019 and 2020 were com-
pared in categorical variables using chi- squared test (test 
statistic denoted by χ²; degrees of freedom by df). When 
not valid, Fisher’s exact test was used (test statistic denot-
ed by FI; degrees of freedom by df). Where distributional 
assumptions could be made, the years 2019 and 2020 
were compared in the mean of continuous variables us-
ing the independent- samples t- test (test statistic denoted 
by t; degrees of freedom by df); otherwise the Mann- 
Whitney U test (test statistic denoted by U; degrees of 
freedom by df) was used to test for differences between 
years in the distribution of variables. The critical level of 
significance was 5% (0.05). Traditional statistical hypoth-
esis testing with a two- sided alternative was employed. 
No adjustment was made for multiple hypothesis testing.
Categorical data were presented as frequencies and 
percentages. When distributional assumptions could be 
made, then continuous variables were presented using 
the descriptive statistics of the mean, standard deviation, 
median, lower quartile and upper quartile, plus minimum 
and maximum. When distributional assumptions could 
not be made for in continuous variables, the descriptive 
statistics of the median, lower quartile and upper quar-
tile, plus minimum and maximum were presented.
Results
In total, 1,243 theatre visits were analyzed as part of the 
study. Of these, 834 patients presented in 2019 and 409 
in 2020, representing a 51% decrease in cases under-
going emergency surgery. The distribution of these cases 
is shown in Table  I, along with baseline demographic 
data. No statistically significant difference was found 
between 2019 and 2020 for sex (p = 0.510, chi- squared 
test), age (p = 0.204, independent- samples t- test), or 
mechanism (p = 0.069, chi- squared test). Absolute figures 
do show a reduction in the number of sporting injuries 
treated from 3.8% in 2019 to 0.7% in 2020. Although no 
statistically significant differences in time to surgery were 
observed, there was a trend favouring reduction in same 
day surgery (categorized as same calendar day as admis-
sion), from 31.3% in 2019 to 26.2% in 2020. There were 
increases in delays of one calendar day (26.1% to 27.6%), 
two days (9.6% to 12.5%) and three days or more (33% 
to 33.7%), although not statistically significant overall (p 
= 0.178, chi- squared test).
Statistically significant increases were seen from 
2019 to 2020 in percentage of thoracic (3.2% vs 0.7%; 
p = 0.011, chi- squared test), vascular (4.9% vs 2.3%; p 
= 0.013, chi- squared test), and plastics surgeries (18.1% 
vs 8.5%; p = 0.000, chi- squared test). Analysis of the 
nature of procedures revealed fewer open reduction and 
internal fixations (ORIFs) in 2020 (33.5% vs 38.2%) and 
an increase in the number of orthoplastic cases in 2020 
(8.3% vs 2.2%), both statistically significant results (p < 
0.000, chi- squared test). Table  II summarizes details of 
procedures performed.
No statistically significant differences were found in 
American Society of Anaesthesiologists (ASA) score (p = 
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0.059, chi- squared test) nor type of anaesthesia used (p = 
0.795, chi- squared test). Although no statistically signifi-
cant differences in time to surgery were observed, there 
was a trend favouring reduction in same day surgery 
(categorized as same calendar day as admission), from 
31.3% in 2019 to 26.2% in 2020. There were increases 
in delays of one calendar day (26.1% to 27.6%), two 
days (9.6% to 12.5%), and three days or more (33% to 
33.7%), although not statistically significant overall (p = 
0.178, chi- squared test).
Table  III summarizes timings of various stages in 
the patient journey to theatre. There was a statistically 







Female 301 (36.1) 140 (34.2) χ² = 0.44
df = 1
p = 0.510
Male 533 (63.9) 269 (65.8)
Age, yrs




95% CI -4.62 to 
0.99





MTC 1 360 (43.2) 119 (29.1)
MTC 2 282 (33.8) 164 (40.1)
MTC 3 86 (10.3) 43 (10.5)
MTC 4 106 (12.7) 83 (20.3)
Mechanism, n (%)
RTC 213 (25.5) 104 (25.4) χ² = 11.72
df = 6
p = 0.069
Assault (blunt) 31 (3.7) 12 (2.9)
Assault (penetrating) 57 (6.8) 29 (7.1)
Fall < 2 m 224 (26.9) 109 (26.7)
Fall > 2 m 85 (10.2) 52
Sports 32 (3.8) 3
Other 192 (100) 100
Neurosurgery, n (%)
No 788 (94.6) 383 (93.6) χ² = 0.457
df = 1
p = 0.499
Yes 45 (5.4) 26 (6.4)
Thoracic, n (%)
No 826 (99.3) 396 (96.8) χ² = 10.96
df = 1
p = 0.01
Yes 6 (0.7) 13 (3.2)
General surgery, n 
(%)
No 772 (92.7) 367 χ² = 3.11
df = 1
p = 0.078
Yes 61 (7.3) 42 (10.3)
Vascular, n (%)
No 814 (97.7) 389 (95.1) χ² = 6.12
df = 1
p = 0.013
Yes 19 (2.3) 20 (4.9)
ENTMF, n (%)
No 790 (94.8) 386 (94.4) χ² = 0.11
df = 1
p = 0.737
Yes 43 (5.2) 23 (5.6)
Plastics, n (%)




Yes 71 (8.5) 74
ASA grade, n (%)
I 363 (43.7) 176 (43.0)
II 304 (36.6) 126 (30.8)
II 119 (14.3) 76 (18.6)
IV 42 (5.1) 28 (6.8)
V 2 (0.2) 3 (0.7)








Same day 261 (31.1) 107 (26.2) χ² = 4.91
df = 3
p = 0.178
Next day 217 (26.1) 113 (37.6)
Two days later 80 (9.6) 51 (12.5)
Three or more days later 275 (33.0) 138 (33.7)
Type of anaesthesia, 
n (%)
General anaesthetic 820 (98.9) 402 (96.8) FI = 1.48
df = 3
p = 0.795
Local anaesthetic 7 (0.8) 5 (1.2)
Sedation 1 (0.1) 0 (0.0)
Spinal 1 (0.1) 0 (0.0)
χ², chi- squared test; ASA, American Society of Anaesthesiologists; CI, 
confidence interval; df, degrees of freedom; ENTMF, ear, nose and throat, 
maxillofacial; FI, Fisher’s exact test; t, independent- samples t- test.
Table I. Continued






n (%) Test statistics
Orthopaedic
Upper limb 123 (15.2) 55 (13.4) χ² = 11.29
df = 6
p = 0.080
Lower limb 416 (51.4) 211 (51.6)
Pelvis 98 (12.1) 57 (13.9)
Elective 2 (0.2) 0 (0.0)
Spine 24 (3.0) 17 (4.2)
N/A 151 (18.1) 69 (16.9)
Operation type
IM nail 104 (12.5) 47 (11.5) χ² = 38.73
df = 11
p = 0.000
ORIF 318 (38.2) 137 (33.5)
Ex- fix 38 (4.6) 24 (5.9)
Soft tissue 54 (6.5) 20 (4.9)
Abdominal 36 (4.3) 14 (3,.4)
Head 26 (3.1) 4 (1.0)
Chest 7 (0.8) 2 (0.5)
Vascular 9 (1.1) 8 (2.0)
Plastic 50 (6.0) 33 (8.1)
ENT 5 (0.6) 4 (1.0)
Other 168 (20.2) 82 (20.0)
Orthoplastic 18 (2.2) 34 (8.3)
χ², chi- squared test; df, degrees of freedom; ENT, ear, nose, and throat; 
IM, intramedullary; N/A, not applicable; ORIF, open reduction and internal 
fixation.
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significant increase in median time from 2019 to 2020, 
between sending for a patient and their arrival to the 
anaesthetic room (29 vs 35 minutes; p = 0.000, Mann- 
Whitney U test). Median time between arrival in the 
anaesthetic room and commencement of anaesthetic 
increased (seven to nine minutes; p = 0.104, Mann- 
Whitney U test). With regards to anaesthetic time, 
although not statistically significant, all descriptive statis-
tics showed an increase between 2019 and 2020. The 
median anaesthetic time increased from 165 minutes in 
2019 to 167 minutes in 2020 (p = 0.091, Mann- Whitney 
U test). Overall procedure time showed a non- statistically 
significant increase from 98 minutes in 2019 to 101 
minutes in 2020 (p = 0.322, Mann- Whitney U test). 
Median overall theatre time, defined as time from arrival 
in the anaesthetic room to departure of theatre, showed 
a non- statistically significant increase from 175 minutes in 
2019 to 180 minutes in 2020 (p = 0.061, Mann- Whitney 
U test), with an increasing trend in nearly all descriptive 
statistics.
Discussion
The four London level 1 MTCs are well prepared for major 
incidents, with rehearsed protocols for what typically are 
large casualty, single events within a short timeframe. The 
COVID- 19 pandemic has presented a different challenge, 
with a prolonged and progressive pressure on healthcare 
services requiring longer- term restructuring of normal 
healthcare provision.
All four of the MTCs involved in this study underwent 
restructuring as part of an emergency response, rediverting 
resources to manage the COVID- 19 burden. This restruc-
turing and redeployment was described in a recent publica-
tion and was the same across the four units.3
The resultant reconfiguration has seen operating rooms 
used as extensions to critical care, with redistribution of 
ventilators and a resultant 50% to 75% reduction in oper-
ating capacity across all MTCs. Anaesthetic colleagues have 
been redeployed to intensive care for their airway skills and 
surgical teams were broken up. Modified anaesthetic proto-
cols and PPE routines led to a perception of reduced produc-
tivity. At the outset, our expectation was that the disruption 
to normal routines and protocols would strongly adversely 
affect theatre efficiency.
In reality, however, although overall our data show that 
efficiency was negatively impacted, it also reveals only 
modest differences between the pre- COVID- 19 and COVID- 19 
periods, and, in most cases, only differences of a few minutes 
throughout the patient journey. The reality of the situation 
was not as bad as had been expected, and the resilience of 
the emergency restructuring process is reassuring.
Our collaborative experience across London's MTCs 
during the first wave of COVID- 19 has assessed the impact of 
pandemic on service provision, productivity, and theatre effi-
ciency. During the COVID- 19 study period, there was a 51% 
reduction in the number of surgical cases performed. Part 
of this related to the reduction in presentations due to the 
national lockdown; however, this may also reflect changes in 
decision- making and management of injuries to rationalize 
services and protect patients from COVID- 19. This theory 
is supported by the statistically significant reduction in the 
percentage of ORIF procedures performed during the 2020 
study period.
Time from admission to theatre, a marker for how 
quickly patients were operated upon, deteriorated during 
the COVID period. The number of same day procedures 
reduced, with resultant increases in those being operated 
one to three days post admission, the largest increase 
being in those waiting for two days for surgery. In the 
2019 period, 478/834 patients (57.4%) were operated 
Table III. Timings of various stages in the patient journey to theatre, from 





sending for and 
anaesthetic room 
arrival, mins
Frequency, n 834 409 U = 190,704.0
p = 0.000Median (IQR) 29 (19 to 40) 35 (20 to 44)
Minimum to maximum 0 to 1,420 0 to 975
Time between 
anaesthetic 
room arrival and 
anaesthetic start, 
mins
Frequency, n 834 409 U = 176,151.5
p = 0.104Median (IQR) 7 (5 to 14) 9 (5 to 15)
Minimum to maximum 0 to 190 0 to 1,268
Time between start 
of anaesthetic and 
patient left theatre, 
mins
Frequency, n 834 409 U = 177,599.5
p = 0.091Median (IQR) 165 (110 to 230) 167 (124 to 250)
Minimum to maximum 13 to 565 16 to 940
Time between 
procedure start and 
stop time, mins
Frequency, n 834 409 U = 171,192.0
p = 0.322Median (IQR) 98 (60 to 155) 101 (60 to 158)




and patient leaving 
anaesthetic room 
and theatre, mins
Frequency, n 834 409 U = 178,665.5
p = 0.061Median (IQR) 175 (119 to 242) 180 (136 to 263)
Minimum to maximum 23 to 571 18 to 955
IQR, interquartile range; U, Mann- Whitney U test.
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on within two days of admission, compared to 220/409 
patients (53.7%) in 2020. It stands to reason that reduced 
capacity, potentiated by reduced efficiency, led to delays 
in treatment.
There was a significant increase in the duration 
between sending for a patient and them arriving in the 
anaesthetic room. Raw data showed increases in anaes-
thetic start time after arrival in the anaesthetic room, 
overall anaesthetic time, overall procedure time, and 
overall time in theatre.
Literature for comparison is limited. Our findings are 
supported by the data from available studies. Khadabadi 
et al4 evaluated 45 full- day lists in 2019 and 50 full- day lists 
in 2020 during April and May. They found that operative 
time and anaesthetic time went up significantly in 2020 in 
comparison to 2019. Karia et al5 presented some data on 
theatre usage in their paper on the outcome of COVID- 19 
in district general hospital practice. They found statistically 
significant increases in time to leave theatre (defined as the 
time between completing the procedure and leaving the 
operating theatre) from six to eight minutes (p < 0.001, 
Mann- Whitney U test). They also found that mean turn 
around (time between the patient leaving the operating 
theatre and the next patient arriving in the anaesthetic room) 
increased significantly by 46.5 minutes from 13.0 minutes 
in April 2019 to 59.5 minutes during lockdown (p < 0.001, 
Mann- Whitney U test).
Our data shows that delays were present at each step 
of the patient journey. Reduced theatre availability, rede-
ployment of staff, and stringent infection control, including 
prolonged cleaning protocols, were all necessary steps in 
service and process reconfiguration but with the resultant 
impact of delays. Whether this influenced patient care is pres-
ently answered. However, further data pending publication 
from our collaborative, looking at outcomes patients during 
the COVID- 19 first wave, shows resilience of the MTC health-
care system during the early COVID- 19 pandemic. Despite 
the restructuring of services, the London MTCs were able to 
perform to their normal high standards, and were able to 
deliver care to the major trauma patients in an appropriate 
and timely fashion.
The widespread impact of reduced efficiency in theatre 
should not be underestimated. Fewer cases completed each 
day leads to, as we have demonstrated, patients waiting 
longer for their surgery. Extended periods of preoperative 
pain and increased risk of preoperative complications in 
immobile patients have both physical and psychological 
impact. Resultant prolonged hospital admissions potentially 
increase risks of hospital- acquired infections and currently, 
COVID- 19.6- 8 There is also the financial consequence of 
inefficiency, with the operating theatre already identified 
as a prominent cause of financial waste in the NHS due to 
inefficiency.9
There are limitations to the study. The data relates to the 
first wave of the COVID- 19 pandemic. As we approach a 
potential third wave now in 2021, it is important to appre-
ciate that this has been a rapidly changing situation, and that 
protocols have evolved since the early days of the pandemic. 
In addition, the success of the vaccination programme in the 
UK has significantly improved the situation by, at very least, 
reducing hospitalizations and severity of the disease in vacci-
nated individuals. Appreciating the change in circumstances, 
it remains important to learn from our initial response 
to a large- scale, rapid evolving situation that pushed the 
resources of the NHS more than it has ever experienced.
The study was performed in the MTC setting and some 
questions may be raised regarding extrapolating results to 
the non- MTC setting. Regardless of size, many hospitals 
experienced the same problems with workload and restruc-
turing/redeployment that we have discussed in this paper. 
Although the case mix may be different to other hospital 
settings, the workings of our remaining trauma provision 
would be no different, with the processes and associated 
delays expected to be similar in other settings.
Two further questions relate to the accuracy of the timing 
data, and whether these statistically significant and equally 
non- significant data are clinically meaningful. Each unit 
recorded the same ‘timings’ data as part of the electronic 
theatre record. These were all to the nearest second, with no 
evidence of rounding. However, we accept that there could 
well have been lack of precision in recording the measure-
ments. Regarding clinical meaningfulness, this is difficult 
to categorically answer. Do changes of between two and 
six minutes actually have a clinical impact? Our data reflect 
our opinion that the changes seen were not as bad as were 
expected, given the severe restriction of service and new 
infectious disease protocols.
This study does goes some way to quantifying reduced 
productivity under the conditions set- out by COVID- 19 
restructuring, and we are the first multicentre MTC to do so. 
All of our centres experienced surges in COVID- 19 admis-
sions; reorganization of services was extensive to support 
this. This was not the case in other regions of the UK, where 
changes to services may have been less pronounced, 
meaning that extrapolation of these results may be chal-
lenging. Our circumstances did, at times, represent a worst- 
case scenario, which can now be planned for.
Understanding the nature of the delays will allow 
some mitigation of the effect (e.g. sending for patients 
earlier knowing that they take longer to arrive to theatre), 
as well as enabling better workload planning in further 
COVID- 19 waves.
In conclusion, realistic insight into what can be achieved 
in in a trauma list and the delays that exists will better enable 
workload planning in further COVID- 19 waves. The changes 
in working practices necessitated by COVID- 19 led to modest 
delays to all aspects of theatre usage, and consequently, 
theatre efficiency. However, the reality is that the major 
concerns of impact of service did not occur to the levels that 
were expected.
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Take home message
  - Emergence of the COVID- 19 pandemic resulted in dramatic 
changes in global healthcare provision.
  - We describe the impact of this on the provision of 
major trauma care in a major capital city and have shown how this 
negatively impacted on theatre efficiency.
  - Widespread delays were noted throughout the patient journey from 
admission to theatre. However, the reality ultimately was not as bad 
as was anticipated.
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